We are monitoring the impact of COVID-19 on Europe Nuclear Medicine Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 100
Share on
Share on

Europe Nuclear Medicine Diagnostics Market Research Report - Segmented By SPECT, PET, Application & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 100
Pages: 141

Europe Nuclear Medicine Diagnostic Market Size (2021 to 2026)

The nuclear medicine diagnostic market in Europe is predicted to be worth USD 5.85 billion by 2026 from USD 3.38 billion in 2021, growing at a CAGR of 11.60% during the forecast period.

Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians in making a quick, accurate diagnosis of the patient's illness.

The European nuclear medicine diagnostics market is primarily driven by the increasing incidences of cancer and cardiac disorders and the increasing demand for image-guided procedures and diagnostics. Nuclear medicine has shown enormous potential in the treatment of heart disease and cancer. According to the WHO, an estimated 3.85 million new cases and 1.95 million deaths occur each year from cancer. Cancer diseases are the second leading cause of death and morbidity in Europe.

According to the World Health Organization (WHO) estimates, in 2018, 18.9 million people died from cardiovascular disease; due to the increase in cardiac diseases, the applications of nuclear medicine will also continue to show strong growth in the market. In addition, there are also other factors such as an increase in SPECT and PET usage and growing public awareness of healthcare, which are expected to drive the future market.

Government initiatives and funding to develop new techniques are expected to stimulate the European nuclear medicine diagnostics market. For example, in 2019, the European Regional Development Fund (EFRO) and the Kansen voor West organization paid NRG $ 7.77 million for FIELD-LAB, developing new nuclear drugs to treat cancer. This is expected to have a positive impact on the European nuclear medicine diagnostics market in upcoming years. 

There is great competition between companies in the European nuclear medicine diagnostics market. In addition, large companies in the pharmaceutical and biotechnology industries are leveraging their huge reserves of capital to enter this market, further increasing competition which helps develop the market.

However, regulatory requirements are the main obstacle to translational research and clinical investigations. In Europe, all guidelines for nuclear medicine products are coordinated by the European Association of Nuclear Medicine (EANM) and, including radiopharmaceuticals and diagnostic radiation therapy, are subject to the European Medicines Agency (EMEA). Therefore, radiopharmaceuticals are subject to unique regulatory and approval pathways, which is time-consuming. In addition, extensive toxicological tests sometimes impose a considerable financial burden on researchers. Factors such as the shortage of skilled workers to operate nuclear medicine diagnostics and competition from conventional diagnostic procedures hamper the growth of the European nuclear medicine diagnostics market.

This research report on the Europe Nuclear Medicine Diagnostics Market is segmented and sub-segmented into the following categories:

By Type:

  • SPECT
  • PET

By Application:

  • Cardiology
  • Lymphoma
  • Thyroid
  • Neurology
  • Oncology
  • others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

In 2020, Germany represented the largest share of the European nuclear medicine diagnostics market, followed by France, Italy, the United Kingdom, Spain, and Russia. However, in the upcoming years, the European nuclear medicine diagnostics market is expected to experience the strongest growth in the rest of European countries, particularly in Switzerland, Poland, Denmark, Sweden, and the Netherlands.

The European nuclear medicine diagnostics market is very competitive, as there are several large and many small companies offering similar product offerings. These companies adopt various strategies such as agreements, contracts, acquisitions, market developments, expansions, website launches, marketing and promotion activities, and technological improvements to increase their market share and establish a strong presence in the European market.

In 2020, France had good market growth owing to the development of new technologies for radioisotope production, government funding, and business initiatives in the region.

KEY MARKET PLAYERS:

A few of the promising companies operating in the European Nuclear Medicine Diagnostics Market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging & Mallinckrodt plc.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction       

                2.2 Analysis Design 

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline  

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences 

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers  

                4.2 Market Restraints                                                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

  1. Market Segmentation

                5.1 By Type

                                5.1.1 SPECT                                        

                                                5.1.1.1 Technetium-99m                              

                                                5.1.1.2 Thallium-201                       

                                                5.1.1.3 Gallium-67                           

                                                5.1.1.4 Iodine-23                             

                                                5.1.1.5 Others                   

                                5.1.2 PET                                             

                                                5.1.2.1 Fluorine-18                          

                                                5.1.2.2 Rubidium-82                       

                                                5.1.2.3 Others                   

                5.2 By Application   

                                5.2.1 Cardiology                                               

                                5.2.2 Lymphoma                                              

                                5.2.3 Thyroid                                     

                                5.2.4 Neurology                                               

                                5.2.5 Oncology                                 

                                5.2.6 Others                                      

  1. Geographical Analysis

                6.1 Introduction       

                6.2 U.K                                                 

                6.3 Spain     

                6.4 Germany                                                     

                6.5 Italy       

                6.6 France  

  1. Strategic Analysis

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GE Healthcare   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Cardinal Health Inc.                                                 

                8.3 Bracco Imaging S.p.A      

                8.4 Eczacibasi-Monrol Nuclear Products                                                

                8.5 Nordion, Inc.      

                8.6 Bayer Healthcare                                                     

                8.7 Lantheus Medical Imaging, Inc.  

                8.8 Advanced Accelerator Applications S.A. 

                8.9 IBA Molecular Imaging   

                8.10 Mallinckrodt plc.                                                    

  1. Competitive Landscape

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  2. Europe Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  3. Europe SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  6. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  10. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  13. Europe Technetium-99m Market, By Region, From 2021 to 2026 (USD Million)
  14. Europe Thallium-201 Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe Gallium-67 Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Iodine-23 Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Other SPECT Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  19. Europe Fluorine-18 Market, By Region, From 2021 to 2026 (USD Million)
  20. Europe Rubidium-82 Market, By Region, From 2021 to 2026 (USD Million)
  21. Europe Other PET Diagnostic Radioisotopes Market, By Region, From 2021 to 2026 (USD Million)
  22. U.K Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  23. U.K Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  24. Spain Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  25. Spain Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  26. Germany Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  27. Germany Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  28. Italy  Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  29. Italy  Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  30. France Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  31. France Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  32. U.K SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  33. Spain SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  34. Germany SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  35. Italy  SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  36. France SPECT Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  37. U.K PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  38. Spain PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  39. Germany PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  40. Italy  PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)
  41. France PET Diagnostic Radioisotopes Market, By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample